Medication info

Dapael Tablet 10 mg (Dapagliflozin)

Prescription medicationTabletOralExpired
Ingredient · strength
Dapagliflozin›10mg / 1 tablet
Manufacturer / importer
HLB Pharmaceuticals Co., Ltd.
Appearance
Yellow, biconvex, rhomboid film-coated tablet
Packaging
100 tablets/bottle, 8 tablets/box [8 tablets/Alu-Alu x 1]
Approval status
Expired

MFDS item code 202100053 · Approved 2021.01.05

This product's status changed to Expired on 2026.01.05. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, the recommended initial dose of this medicine when administered with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR below 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dosage adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dosage adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. Swallow the tablet whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
HLB Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Difficulty in controlling blood sugar levels in patients with type 2 diabetes
View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes in conjunction with diet and exercise. It can be taken alone or in combination with other diabetes medications such as Metformin, Sulfonylureas, Insulin, or Sitagliptin if blood sugar control is difficult. These combination therapies help manage the patient's blood sugar levels more effectively. Therefore, this drug is used to improve blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, the recommended initial dose of this medicine when administered with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR below 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dosage adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dosage adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. Swallow the tablet whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be given to certain patients. First, it should not be used by patients who are allergic to the active ingredient or excipients, those with type 1 diabetes, or those with diabetic ketoacidosis. Additionally, patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should avoid this medication due to the presence of anhydrous lactose. It should also not be used in patients undergoing dialysis. Caution should be exercised when administering to patients with reduced fluid volume or kidney dysfunction. This medication can cause a decrease in blood pressure or temporary changes in kidney function, and the risk may be greater in elderly patients with impaired kidney function or those taking diuretics. Therefore, fluid volume status and kidney function should be assessed before administration, and after administration, symptoms of hypotension and kidney function should be monitored carefully. The blood sugar control effect of this drug may vary depending on kidney function. In patients with moderate renal impairment, its blood sugar control effect may be diminished, and in type 2 diabetes patients with an eGFR below 45 mL/min/1.73 m2, it is not recommended for blood sugar control purposes. Common adverse reactions that may occur while taking this medication include genital infections. These occur more frequently in women, and appropriate treatment is necessary if an infection develops. Other possible symptoms include urinary tract infections, hypoglycemia, reduction in fluid volume, dizziness, constipation, dry mouth, lower back pain, dysuria, polyuria, and nocturia. Diabetic ketoacidosis may occur, so if symptoms of ketoacidosis appear even when blood sugar levels are in the normal range, immediate treatment is required. Symptoms of ketoacidosis include nausea, vomiting, abdominal pain, fatigue, and difficulty breathing, which should be heeded. This medication can cause a decrease in fluid volume, so patients with dehydration symptoms or at risk of hypotension should be cautious. If reduced fluid volume is suspected, administration should be temporarily suspended and status restored. Elderly patients are at higher risk of hypotension due to decreased kidney function or use of antihypertensive agents, so additional caution is necessary. This medication can increase the risk of hypoglycemia when used with Insulin or Sulfonylureas, so dose adjustments may be necessary when used in combination with these medications. Pregnant women should not use this medication, and treatment should be discontinued immediately if pregnancy is confirmed. Additionally, nursing mothers should not take this medication. This medication does not significantly affect driving or machine operation, but caution is required due to the risk of hypoglycemia. Finally, the safety and efficacy of this drug in children have not been established, so it is not used in pediatric patients.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, reduced fluid volume, polydipsia, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, decreased renal creatinine clearance at the beginning of treatment, dyslipidemia, elevated creatinine in the blood at the beginning of treatment, increased blood urea, weight loss, rash, angioedema, urosepsis, pyelonephritis, acute kidney injury, renal impairment

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air or moisture, so it must be stored in a tightly closed container. It is best to store it at room temperature between 1 and 30 degrees Celsius. This will help maintain the medication's efficacy over time.

Appearance and packaging

Appearance

Yellow, biconvex, rhomboid film-coated tablet

Package unit

100 tablets/bottle, 8 tablets/box [8 tablets/Alu-Alu x 1]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.